[ ]   [ ]   [ ]                        [ ]      [ ]   [ ]

Cache stopped working on old Android Phone - Eisenwindel - Mar 19, 2024 - 1:50am
 
Trump - NoEnzLefttoSplit - Mar 19, 2024 - 12:27am
 
Israel - R_P - Mar 18, 2024 - 11:09pm
 
Wordle - daily game - NoEnzLefttoSplit - Mar 18, 2024 - 10:26pm
 
Photography Forum - Your Own Photos - fractalv - Mar 18, 2024 - 9:09pm
 
March 2024 Photo Theme - Many - fractalv - Mar 18, 2024 - 9:08pm
 
Live Music - oldviolin - Mar 18, 2024 - 8:24pm
 
Cryptic Posts - Leave Them Guessing - Bill_J - Mar 18, 2024 - 8:23pm
 
Damn Dinosaurs! - oldviolin - Mar 18, 2024 - 8:16pm
 
New Forum Member on "What Makes RP Great" - oldviolin - Mar 18, 2024 - 8:02pm
 
Name My Band - oldviolin - Mar 18, 2024 - 8:00pm
 
Irony 101 - oldviolin - Mar 18, 2024 - 7:55pm
 
Radio Paradise Comments - oldviolin - Mar 18, 2024 - 7:35pm
 
One Partying State - Wyoming News - geoff_morphini - Mar 18, 2024 - 3:58pm
 
Great guitar faces - skyguy - Mar 18, 2024 - 3:33pm
 
The Obituary Page - kurtster - Mar 18, 2024 - 1:51pm
 
Despots, dictators and war criminals - R_P - Mar 18, 2024 - 12:41pm
 
Uploading Music - dischuckin - Mar 18, 2024 - 11:55am
 
Media Matters - thisbody - Mar 18, 2024 - 10:03am
 
NYTimes Connections - geoff_morphini - Mar 18, 2024 - 8:26am
 
Bug Reports & Feature Requests - jarro - Mar 18, 2024 - 6:37am
 
Today in History - DaveInSaoMiguel - Mar 18, 2024 - 5:42am
 
NASA & other news from space - miamizsun - Mar 18, 2024 - 4:13am
 
2024 Elections! - R_P - Mar 17, 2024 - 11:43am
 
Basketball - geoff_morphini - Mar 17, 2024 - 11:11am
 
MEALTICKET - drinpt - Mar 17, 2024 - 4:13am
 
What makes you smile? - Steely_D - Mar 16, 2024 - 7:31pm
 
Musky Mythology - R_P - Mar 16, 2024 - 2:07pm
 
Apple Computer - GeneP59 - Mar 16, 2024 - 12:02pm
 
Mixtape Culture Club - Steely_D - Mar 16, 2024 - 11:41am
 
Environment - R_P - Mar 16, 2024 - 11:18am
 
RightWingNutZ - R_P - Mar 16, 2024 - 10:48am
 
Caching to Apple watch quit working - lsiegel - Mar 16, 2024 - 8:12am
 
Talk Behind Their Backs Forum - VV - Mar 15, 2024 - 2:47pm
 
Joe Biden - black321 - Mar 15, 2024 - 2:33pm
 
Artificial Intelligence - miamizsun - Mar 15, 2024 - 12:15pm
 
the Todd Rundgren topic - Steely_D - Mar 15, 2024 - 11:01am
 
Things You Thought Today - kurtster - Mar 15, 2024 - 10:37am
 
Republican Party - islander - Mar 15, 2024 - 9:08am
 
How's the weather? - miamizsun - Mar 15, 2024 - 6:53am
 
Radio Paradise app on Android is broken - timmus - Mar 15, 2024 - 5:25am
 
Ukraine - NoEnzLefttoSplit - Mar 14, 2024 - 10:17pm
 
Democratic Party - R_P - Mar 14, 2024 - 3:04pm
 
The Chomsky / Zinn Reader - thisbody - Mar 14, 2024 - 2:00pm
 
Unquiet Minds - Mental Health Forum - thisbody - Mar 14, 2024 - 1:54pm
 
USA! USA! USA! - thisbody - Mar 14, 2024 - 12:31pm
 
China - R_P - Mar 14, 2024 - 11:52am
 
Android App Problems After Update - jarro - Mar 14, 2024 - 12:58am
 
Russia - NoEnzLefttoSplit - Mar 13, 2024 - 11:59am
 
It's the economy stupid. - kurtster - Mar 13, 2024 - 11:22am
 
How do I get songs into My Favorites - ScottFromWyoming - Mar 13, 2024 - 10:11am
 
Jazz channel? - Steely_D - Mar 13, 2024 - 9:13am
 
Vinyl Only Spin List - kurtster - Mar 13, 2024 - 2:01am
 
What Makes You Laugh? - miamizsun - Mar 12, 2024 - 11:17am
 
Frequent drop outs (The Netherlands) - ScopPics - Mar 12, 2024 - 7:20am
 
If not RP, what are you listening to right now? - Beaker - Mar 11, 2024 - 12:37am
 
• • • What Makes You Happy? • • •  - Red_Dragon - Mar 10, 2024 - 11:02am
 
female vocalists - Steely_D - Mar 10, 2024 - 9:13am
 
New Music - whatshisname - Mar 9, 2024 - 4:27pm
 
Other Medical Stuff - Coaxial - Mar 9, 2024 - 1:09pm
 
Outstanding Covers - skyguy - Mar 9, 2024 - 9:23am
 
Ridiculous or Funny Spam - KurtfromLaQuinta - Mar 9, 2024 - 8:31am
 
Oh dear god, BEES! - KurtfromLaQuinta - Mar 9, 2024 - 8:24am
 
Maybe it's just the beer talking... - Proclivities - Mar 8, 2024 - 12:04pm
 
History - lather, rinse, repeat. - R_P - Mar 8, 2024 - 10:12am
 
Big Pharma - black321 - Mar 8, 2024 - 9:33am
 
Can't find Radio 2050 in my Ocean Digital Tuner - sjagminas1 - Mar 8, 2024 - 7:57am
 
• • • The Once-a-Day • • •  - oldviolin - Mar 7, 2024 - 6:50pm
 
Music Videos - Red_Dragon - Mar 7, 2024 - 6:21pm
 
Climate Change - Manbird - Mar 7, 2024 - 2:58pm
 
what else do you listen to? (RP alternatives) - haresfur - Mar 7, 2024 - 1:43pm
 
~ Have a good joke you can post? ~ - black321 - Mar 7, 2024 - 12:17pm
 
Lyrics that strike a chord today... - oldviolin - Mar 7, 2024 - 11:56am
 
Did the punishment fit the Crime? - oldviolin - Mar 7, 2024 - 11:43am
 
The US of A telling Russia not to invade Ukraine is like... - GeneP59 - Mar 7, 2024 - 8:42am
 
Index » Radio Paradise/General » General Discussion » XPRIZE & Singularity University Page: 1, 2, 3  Next
Post to this Topic
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2022 - 8:41am

didn't see an AI thread so this will have to do for now...




edit: full version


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 31, 2019 - 3:15pm


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Mar 12, 2019 - 6:12am

sort of the euro-version of singularity u 

Hello Tomorrow

We are a global non-profit on a mission to unlock the potential of deep technologies to solve the world's toughest challenges, by highlighting, empowering and connecting the most promising deeptech entrepreneurs across the globe with the right enablers.






black321

black321 Avatar

Location: An earth without maps
Gender: Male


Posted: Jan 25, 2019 - 9:59am



 miamizsun wrote:
busy day ahead, but i'd like to leave you with something good to snack on


 

I'll see your exponential tech, and raise you one big brother:

https://www.wired.com/story/is...
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 25, 2019 - 4:21am

busy day ahead, but i'd like to leave you with something good to snack on


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Sep 16, 2018 - 8:16am



an awesome display of people using technology to solve the biggest problems we have today (and in the future)  

this is much watch stuff (esp the energy presentation with ramez naam)

enjoy  










miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 3:48pm

Landmark FDA Approval Brings Powerful Gene Silencing Method to Market

Earlier this month, the FDA approved an entirely new family of drugs, one so powerful that it could put CRISPR-based gene therapy to shame. Backed by two decades of research and a Nobel Prize, these drugs have the ability to cure inherited diseases—and do so without actually needing to edit the delicate genome.

The green-lit therapy is patisiran, a drug ten years in the making by the Cambridge-based Alnylam for genetic nerve damage. But in this rare case, the nature of the drug is perhaps more significant: patisiran is based on a technology called RNA interference, or RNAi, which allows doctors to silence genes that aren’t properly functioning.

Patisiran is just the tip of the iceberg. In theory, RNAi has the potential to cure any disease caused by “bad” proteins, such as stroke, Alzheimer’s, high cholesterol, or other neurodegenerative disorders. The potential is so grand that scientists have long dubbed the technology a way to “drug the undruggable.”

“This approval is part of a broader wave of advances that allow us to treat disease by actually targeting the root cause, enabling us to arrest or reverse a condition, rather than only being able to slow its progression or treat its symptoms,” said FDA commissioner Scott Gottlieb in a press release. “New technologies like RNA inhibitors, that alter the genetic drivers of a disease, have the potential to transform medicine, so we can better confront and even cure debilitating illnesses.”

With other RNA-based therapies hurtling down the drug development pipeline, it’s likely we’ll be seeing more of these drugs soon. Here’s what you need to know.
more


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 1:46pm

i'm fairly certain that anyone can sign up and livestream this summit

line up of speakers/presenters here

e
njoy
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:33am

 islander wrote:

{#Ask}  

So when do we get to trial run the set?

 
when is now a good time?    {#Cheers}

miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:23am



Proclivities

Proclivities Avatar

Location: Paris of the Piedmont
Gender: Male


Posted: Aug 7, 2018 - 9:21am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
Good to see you; your secret is safe.
spy smasher
islander

islander Avatar

Location: Seattle
Gender: Male


Posted: Aug 7, 2018 - 9:03am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
{#Ask}  

So when do we get to trial run the set?


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 7, 2018 - 8:37am

 NoEnzLefttoSplit wrote:

Good to see you back J!

 

 
thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}

NoEnzLefttoSplit

NoEnzLefttoSplit Avatar

Gender: Male


Posted: Aug 7, 2018 - 8:18am

 miamizsun wrote:
from last october (i think there's an updated version of this video)
 

 
Good to see you back J!

 
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 6, 2018 - 2:47pm

from last october (i think there's an updated version of this video)


 


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 22, 2018 - 4:12am

we need people with vision swinging for the fence...


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Apr 9, 2018 - 1:46pm


see more here
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 16, 2018 - 4:23am

Gene Therapy Had a Breakthrough 2017—2018 May Be Even Better

Gene therapy had a hell of a 2017. After decades of promises but failed deliveries, last year saw the field hitting a series of astonishing home runs.

The concept of gene therapy is elegant: like computer bugs, faulty letters in the human genome can be edited and replaced with healthy ones.

But despite early enthusiasm, the field has suffered one setback after another. At the turn of the century, the death of an 18-year-old patient with inherited liver disease after an experimental gene therapy treatment put the entire field into a deep freeze.

But no more. Last year marked the birth of gene therapy 2.0, in which the experimental dream finally became a clinical reality. Here’s how the tech grew into its explosive potential—and a sneak peek at what’s on the horizon for 2018.

1. Bad Blood, Meet CAR-T

It sounds like magic: you harvest a patient’s own immune cells, dose them with an injection of extra genetic material, and turn them into living cancer-hunting machines.

But in 2017, the FDA approved a double whammy of CAR-T immunotherapies. The first, green-lighted in August, helps kids and young adults battle an especially nasty form of leukemia called B-cell acute lymphoblastic leukemia. Two months later, a therapy for adults with non-Hodgkin lymphoma hit the scene.

Together, these approvals marked the long-anticipated debut of gene therapy in the US market. Previously, Europe has led the charge with its approval of Glybera in 2015, a gene therapy that reduces fatty acid buildup in the bloodstream.

The historic nod of confidence for CAR-T has already sparked widespread interest among academics and drug companies alike at finding new targets for the upgraded immune cells (the “T” in “CAR-T” stands for T-cell, a type of immune cell). CAR-T is especially exciting for the cancer field because it helps people who don’t respond to other classic treatments, such as chemotherapy.

Already in the works are treatments that target multiple myeloma, which causes multiple tumors in the bone or soft tissue, and glioblastoma, an aggressive brain tumor for which there is no cure.

But the technology’s potential is hardly limited to cancer. Last year, a preliminary study in two monkeys showed that genetically engineered stem cells can suppress and even eradicate HIV infections. The study, though small, tantalizingly suggests a whole new way to battle HIV after three decades of fruitless search for a vaccine. With multiple CAR-T therapies going through the pipeline, 2018 may very likely welcome new members onto the gene therapy scene.



more here...




miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 11, 2018 - 9:26am

a new cancer xprize...{#Cheers}

The Future of Cancer Treatment Is Personalized and Collaborative

Just a few years ago, microscopes were the primary tool used in cancer diagnoses, but we’ve come a long way since.

“We still look at a microscope, we still look at what organ the cancer started in,” Wender said. “But increasingly we’re looking at the molecular signature. It’s not just the genomics, and it’s not just the genes. It’s also the cellular environment around that cancer. We’re now targeting our therapies to the mutations that are found in that particular cancer.”

Cancer treatments in the past have been largely reactionary, but they don’t need to be. Most cancer is genetic, which means that treatment can be preventative. This is one reason why newer cancer treatment techniques are searching for actionable targets in the specific gene before the cancer develops.

When asked how artificial intelligence and machine learning technologies are reshaping clinical trials, Wender acknowledged that how clinical trials have been run in the past won’t work moving forward.

“Our traditional ways of learning about cancer were by finding a particular cancer type and conducting a long clinical trial that took a number of years enrolling patients from around the country. That is not how we’re going to learn to treat individual patients in the future.”

Instead, Wender emphasized the need for gathering as much data as possible, and from as many individual patients as possible. This data should encompass clinical, pathological, and molecular data and should be gathered from a patient all the way through their final outcome. “Literally every person becomes a clinical trial of one,” Wender said.

For the best cancer treatment and diagnostics, Wender says the answer is to make the process collaborative by pulling in resources from organizations and companies that are both established and emerging.

It’s no surprise to hear that the best solutions come from pairing together uncommon partners to innovate.


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 9, 2018 - 6:43am

it's part of moving forward...

New Research Suggests Immunity to CRISPR Gene Editing Poses a Challenge

The issue arises in how the Cas9 proteins researchers use are manufactured.

The authors of the study noted that the most widely-used versions of the protein are extracted from the bacteria Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). In bioengineering, particular bacteria—usually selected for being widely available and easy to cultivate—are often used to synthesize particular proteins. For example, most of our medical insulin is made from genetically modified E. coli. The researchers behind the study questioned whether because S. aureus and S. pyogenes regularly infect humans we might have built up some resistance to their proteins already. The infections they cause, often called strep and staph, are widespread enough that most people can be expected to have been exposed to the bacteria.

The study discovered that in many cases, human immune systems produced T-cells that specifically responded to the Cas9 protein from Staphylococcus aureus. This suggests that attempts at therapeutic use would cause an adaptive immune response that might render the therapy ineffective. Indeed, the authors of the paper wrote that use of these proteins in those who’ve been exposed to this bacteria could be harmful. “It may even result in significant toxicity to patients,” according to Stanford University’s Matthew Porteus, a  senior author of the paper. A paper by Wei Leong Chew suggests, “If left unchecked…it could lead to mortality.”

The authors of the paper wanted to ensure immune issues weren’t overlooked. “Like any new technology, you want to identify potential problems and engineer solutions for them,” according to Porteus. “And I think that’s where we’re at. This is an issue that should be addressed.”

But this is far from the end for CRISPR.


Page: 1, 2, 3  Next